💫 #MetALD affects women differently. From greater alcohol sensitivity to menopause-related risk and transplant disparities, this review synthesizes evidence on sex-specific biology, outcomes, and care gaps in women with MetALD.

🔗: https://ow.ly/3OKR50ZTbQL

A study from Mazen Noureddin, MD, (of @houstonmethodistmd.bsky.social), found that 11% of patients screened for #MASLD clinical trials had PEth results of ≥20 ng/mL, indicating a potential need for further clinical evaluation for possible #MetALD or #ALD.

www.docwirenews.com/post/phospha...